Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

被引：0
|
作者：
Thomas G. de Leeuw
Laura Mangiarini
Rebecca Lundin
Florentia Kaguelidou
Tjitske van der Zanden
Oscar Della Pasqua
Dick Tibboel
Adriana Ceci
Saskia N. de Wildt
机构：
[1] Erasmus MC-Sophia Children’s Hospital,Department of Anesthesia and Pain Medicine
[2] Consorzio per Valutazione Biologiche e Farmacologiche,Department of Pediatric Pharmacology and Pharmacogenetics
[3] Fondazione Penta Onlus,Intensive Care and Department of Paediatric Surgery
[4] AP-HP,Department of Pharmacology and Toxicology
[5] Hôpital Robert Debré,undefined
[6] Inserm,undefined
[7] CIC 1426,undefined
[8] Université Paris Diderot,undefined
[9] Sorbonne Paris Cité,undefined
[10] EA 08,undefined
[11] Erasmus MC-Sophia Children’s Hospital,undefined
[12] University College London,undefined
[13] Radboud University,undefined
来源：
Trials | / 20卷
关键词：
Gabapentin; Neuropathic pain; Children; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 5 条
  • [1] Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
    Thomas G. de Leeuw
    Laura Mangiarini
    Rebecca Lundin
    Florentia Kaguelidou
    Tjitske van der Zanden
    Oscar Della Pasqua
    Dick Tibboel
    Adriana Ceci
    Saskia N. de Wildt
    Trials, 20
  • [2] Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3months to 18years-evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
    de Leeuw, Thomas G.
    Mangiarini, Laura
    Lundin, Rebecca
    Kaguelidou, Florentia
    van der Zanden, Tjitske
    Della Pasqua, Oscar
    Tibboel, Dick
    Ceci, Adriana
    de Wildt, Saskia N.
    Bali, Donjeta
    Hoxha-Qosja, Alketa
    Kola, Ermira
    Andrieu-Galien, Juliette
    Annequin, Daniel
    Blanchet, Romy
    Desguerre, Isabelle
    Fournier-Charriere, Elisabeth
    Kaguelidou, Florentia
    Tourniaire, Barbara
    Wood, Chantal
    Neubert, Antje
    Trollmann, Regina
    Wimmer, Stefan
    Garini, Eleana
    Mammi, Panagoula
    Allegretti, Marcello
    Bellagamba, Ornella
    Benini, Franca
    Bonifazi, Donato
    Caprino, Daniela
    Ceci, Adriana
    Congedi, Sabrina
    Craig, Francesco
    Dallorso, Sandro
    Divisic, Antuan
    Felisi, Mariagrazia
    Gentile, Marco
    De Giacomo, Andrea
    Lundin, Rebecca
    Manfredini, Luca
    Mangiarini, Laura
    Matera, Emilia
    Margari, Lucia
    Mazza, Alessandro
    Pace, Virgilio
    Di Pede, Chiara
    Petruzzelli, Maria Giuseppina
    Ruffini, Pieradelchi
    Tagliavacca, Luigina
    Traverso, Maria
    TRIALS, 2019, 20 (1)
  • [3] Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial (vol 20, 49, 2019)
    de Leeuw, Thomas G.
    Mangiarini, Laura
    Lundin, Rebecca
    Kaguelidou, Florentia
    van der Zanden, Tjitske
    Della Pasqua, Oscar
    Tibboel, Dick
    Ceci, Adriana
    de Wildt, Saskia N.
    TRIALS, 2019, 20 (1)
  • [4] Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
    Bradley, John S.
    Roilides, Emmanuel
    Btvadhurst, Helen
    Cheng, Karen
    Huang, Li-Min
    MasCasullo, Veronica
    Newell, Paul
    Stone, Gregory G.
    Mwadrous, Margaret
    Wajsbn, Dalia
    Yates, Katrina
    Gardner, Annie
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (09) : 920 - 928
  • [5] Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to &lt;18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial
    Bradley, John S.
    Broadhurst, Helen
    Cheng, Karen
    Mendez, Maria
    Newell, Paul
    Prchlik, Martin
    Stone, Gregory G.
    Talley, Angela K.
    Tawadrous, Margaret
    Wajsbrot, Dalia
    Yates, Katrina
    Zuzova, Antonina
    Gardner, Annie
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (08) : 816 - 824
1